CONTACT INFORMATION
Specialties
Kidney Cancer, Melanoma, Head and Neck Cancer
Locations
Edward Hines, Jr. VA Hospital
Board Certifications
Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Research Keywords
Cancer/Carcinogenesis
Chemotherapeutic Agents
Cytokines
Immune System
Immunotherapy
Interferon
Melanoma
Vaccine
Publications
Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.Jaber,J. J.; Clark,J. I.; Muzaffar,K.; Ruggiero,F. P.; Feustel,P. J.; Frett,M. J.; Zender,C. A.Head & neck 2011 ;33(1):7-12
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.Clark,J. I.; Moon,J.; Hutchins,L. F.; Sosman,J. A.; Kast,W. M.; Da Silva,D. M.; Liu,P. Y.; Thompson,J. A.; Flaherty,L. E.; Sondak,V. K.CANCER 2010 ;116(2):424-431
Clinicopathological review: esthesioneuroblastomaBragg,T. M.; Scianna,J.; Kassam,A.; Emami,B.; Brown,H. G.; Hacein-Bey,L.; Clark,J. I.; Muzaffar,K.; Boulis,N.; Prabhu,V. C.NEUROSURGERY 2009 ;64(4):764-770
Phase I adjuvant radiation with docetaxel in high-risk head and neck cancer.Clark,J. I.; Eisner,R. M.; Hofmeister,C.; Norton,J.; Thomas,S.; Choudhury,A.; Petruzzelli,G.; Lathers,D.; Young,M. R.; Lau,A.; Emami,B.American Journal of Clinical Oncology 2009 ;32(4):396-400
Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation.Levey,S. A.; Bajwa,R. S.; Picken,M. M.; Clark,J. I.; Barton,K.; Leehey,D. J.NDT Plus 2008 ;3( ):154-156
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.Margolin,K.; Atkins,M. B.; Dutcher,J. P.; Ernstoff,M. S.; Smith,J. W.,2nd; Clark,J. I.; Baar,J.; Sosman,J.; Weber,J.; Lathia,C.; Brunetti,J.; Cihon,F.; Schwartz,B.CLINICAL CANCER RESEARCH 2007 ;13(11):3312-3319
Interleukin-2 and cancer therapyMargolin,K. A.; Clark,J. I. 2007 ; (IV, Chapter 17):307-316
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026.Hutchins,L. F.; Moon,J.; Clark,J. I.; Thompson,J. A.; Lange,M. K.; Flaherty,L. E.; Sondak,V. K.CANCER 2007 ;110(10):2269-2275
Xp11.2 translocation renal cell carcinoma in adult patientsFok,C. S.; Picken,M. M.; Meyer,P. N.; Clark,J. I.; Flanigan,R. C.; Quek,M. L.American Urological Association Annual Meeting 2007 ; ( ):
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study.Clark,J. I.; Mehrabi,J.; Sosman,J. A.; Logan,T. F.; Margolin,K. A.; Dutcher,J. P.; Urba,W. J.; Ernstoff,M. S.; McDermott,D. F.; Lau,A. M.; Atkins,M. B.JOURNAL OF IMMUNOTHERAPY 2007 ;30(8):839-846
Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.Meyer,P. N.; Clark,J. I.; Flanigan,R. C.; Picken,M. M.AMERICAN JOURNAL OF CLINICAL PATHOLOGY 2007 ;128(1):70-79
Renal cell cancerClark,J. I.; Hofmeister,C. C.; Keedy,V.; Sosman,J. A. 2006 ; (Chapter 46):782-805
Interleukin-2 as cancer therapyClark,J. I.; Margolin,K. A. 2006 ; (Chapter 20):355-364
Vaccine therapy of malignant melanoma.Farray,D.; Clark,J. I.Clinical and applied immunology reviews 2006 ;6(3):217
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.Worden,F. P.; Moon,J.; Samlowski,W.; Clark,J. I.; Dakhil,S. R.; Williamson,S.; Urba,S. G.; Ensley,J.; Hussain,M. H.CANCER 2006 ;107(2):319-327
Neoadjuvant therapy: an emerging concept in oncologyTanvetyanon,T.; Clark,J. I.; Campbell,S. C.; Lo,S. S.SOUTHERN MEDICAL JOURNAL 2005 ;98(3):338-344
Review.[comment]Farray,D.; Clark,J. I.Clinical Advances in Hematology & Oncology 2005 ;3(5):427-428
Metastatic Melanoma to the Central Nervous System: Case Report and Review of the LiteratureSchneck,M. J.; Patel,A.; Rodriguez-Quinonez,A.; Brown,H. G.; Clark,J. I.; Prabhu,V.; Dafer,R. M.; Biller,J.SEMINARS IN CEREBROVASCULAR DISEASES AND STROKE 2005 ;5(3):217-220
Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes.Paner,G. P.; Turk,T. M.; Clark,J. I.; Lindgren,V.; Picken,M. M.ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 2005 ;129(10):1317-1321
In vitro susceptibilities of ocular isolates to old and new antibioticsDvorak,A. W.; John,T.; Clark,J.; Lyzaka,J.Investigative Ophthalmology & Visual Science 2004 ;45( ):E-abstract 4972
Metastatic juxtaglomerular cell tumor in a 52-year-old man.Duan,X.; Bruneval,P.; Hammadeh,R.; Fresco,R.; Eble,J. N.; Clark,J. I.; Vigneswaran,W. T.; Flanigan,R. C.; Picken,M. M.AMERICAN JOURNAL OF SURGICAL PATHOLOGY 2004 ;28(8):1098-1102
Case report and brief review: IL-2-induced myocarditisEisner,R. M.; Husain,A.; Clark,J. I.CANCER INVESTIGATION 2004 ;22(3):401-404
Renal tumor with overlapping distal nephron morphology and karyotype.Lindgren,V.; Paner,G. P.; Flanigan,R. C.; Clark,J. I.; Campbell,S. C.; Picken,M. M.ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 2004 ;128(11):1274-1278
Nephrectomy in metastatic renal cell carcinomaCampbell,S. C.; Flanigan,R. C.; Clark,J. I.Current Treatment Options in Oncology 2003 ;4(5):363-372
Metastatic renal cell carcinomaFlanigan,R. C.; Campbell,S. C.; Clark,J. I.; Picken,M. M.Current Treatment Options in Oncology 2003 ;4(5):385-390
Posterior marginal mandibulectomy in the management of cancer of the oral cavity and oropharynx.Petruzzelli,G. J.; Knight,F. K.; Vandevender,D.; Clark,J. I.; Emami,B.Otolaryngology - Head & Neck Surgery 2003 ;129(6):713-719
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.Clark,J. I.; Atkins,M. B.; Urba,W. J.; Creech,S.; Figlin,R. A.; Dutcher,J. P.; Flaherty,L.; Sosman,J. A.; Logan,T. F.; White,R.; Weiss,G. R.; Redman,B. G.; Tretter,C. P.; McDermott,D.; Smith,J. W.; Gordon,M. S.; Margolin,K. A.JOURNAL OF CLINICAL ONCOLOGY 2003 ;21(16):3133-3140
Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma.Clark,J. I.; Hofmeister,C.; Choudhury,A.; Matz,G.; Collins,S.; Bastian,R.; Melian,E.; Emami,B.; Petruzzelli,G.CANCER 2001 ;92(9):2334-2340
Treatment strategies and outcomes in low-risk cuteaneous head and neck melanomaJaber,J. J.; Zender,C. A.; Clark,J. I.; Muzaffar,K.; Feustel,P. J.; Frett,M. J. ; ( ):
Education
Medical School
Loyola University Chicago Stritch School of Medicine
Residency
Loyola University Medical Center, Internal Medicine: General
Fellowship
Fox Chase Cancer Center/Temple University Hospital, Hematology & Medical Oncology
Interests & Hobbies
Reading
Triathlon